We evaluated whether 13 single nucleotide polymorphisms (SNPs) identified in genome-wide association studies interact with one another and with reproductive and menstrual risk factors in association with breast cancer risk. DNA samples and information on parity, breastfeeding, age at menarche, age at first birth, and age at menopause were collected through structured interviews from 1,484 breast cancer cases and 1,307 controls who participated in a population-based case–control study conducted in three US states. A polygenic score was created as the sum of risk allele copies multiplied by the corresponding log odds estimate. Logistic regression was used to test the associations between SNPs, the score, reproductive and menstrual factors, and breast cancer risk. Nonlinearity of the score was assessed by the inclusion of a quadratic term for polygenic score. Interactions between the aforementioned variables were tested by including a cross-product term in models. We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs2981582 (FGFR2), rs3817198 (LSP1), rs3803662 (TOX3), and rs6504950 (STXBP4) with breast cancer. Women in the score’s highest quintile had 2.2-fold increased risk when compared to women in the lowest quintile (95 % confidence interval: 1.67–2.88). The quadratic polygenic score term was not significant in the model (p = 0.85), suggesting that the established breast cancer loci are not associated with increased risk more than the sum of risk alleles. Modifications of menstrual and reproductive risk factors associations with breast cancer risk by polygenic score were not observed. Our results suggest that the interactions between breast cancer susceptibility loci and reproductive factors are not strong contributors to breast cancer risk.
Epidemiology Reproductive and menstrual factors Breast cancer Breast cancer susceptibility loci
Genome-wide association study
Minor allele frequency
Single nucleotide polymorphism
This is a preview of subscription content, log in to check access.
The authors are grateful to Dr. Kathleen M Egan for her input and advice over the course of the study. The authors have no conflicts of interest to disclose. This work was supported by the National Institutes of Health Intramural Research funds and grants (R01CA47147, R01CA47305, R01CA69664, U10EY006594), and by the Department of Defense Breast Cancer Research Program (W81XWH-11-1-0047).
Stacey SN, Manolescu A, Sulem P et al (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39:865–869. doi:10.1038/ng2064PubMedCrossRefGoogle Scholar
Thomas G, Jacobs KB, Kraft P et al (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41:579–584. doi:10.1038/ng.353PubMedCrossRefGoogle Scholar
Milne RL, Gaudet MM, Spurdle AB et al (2010) Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res Bcr 12:R110. doi:10.1186/bcr2797CrossRefGoogle Scholar
Reeves GK, Travis RC, Green J et al (2010) Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA, J Am Med Assoc 304:426–434. doi:10.1001/jama.2010.1042CrossRefGoogle Scholar
Mealiffe ME, Stokowski RP, Rhees BK et al (2010) Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 102:1618–1627. doi:10.1093/jnci/djq388PubMedCrossRefGoogle Scholar
Broeks A, Schmidt MK, Sherman ME et al (2011) Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20:3289–3303. doi:10.1093/hmg/ddr228PubMedCrossRefGoogle Scholar
Campa D, Kaaks R, Le Marchand L et al (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103:1252–1263. doi:10.1093/jnci/djr265PubMedCrossRefGoogle Scholar
Rebbeck TR, DeMichele A, Tran TV et al (2009) Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis 30:269–274. doi:10.1093/carcin/bgn247PubMedCrossRefGoogle Scholar
García-Closas M, Egan KM, Abruzzo J et al (2001) Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 10:687–696Google Scholar
García-Closas M, Egan KM, Newcomb PA et al (2006) Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119:376–388. doi:10.1007/s00439-006-0135-zPubMedCrossRefGoogle Scholar
Stacey SN, Manolescu A, Sulem P et al (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40:703–706. doi:10.1038/ng.131PubMedCrossRefGoogle Scholar
Figueroa JD, Garcia-Closas M, Humphreys M et al (2011) Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20:4693–4706. doi:10.1093/hmg/ddr368PubMedCrossRefGoogle Scholar
Long J, Shu X-O, Cai Q et al (2010) Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 19:2357–2365. doi:10.1158/1055-9965.EPI-10-0054CrossRefGoogle Scholar
Bean JA, Leeper JD, Wallace RB et al (1979) Variations in the reporting of menstrual histories. Am J Epidemiol 109:181–185PubMedGoogle Scholar